Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker to announce financial results for its third quarter of fiscal year 2023
04:05pm, Monday, 02'nd Oct 2023
Kalamazoo, Michigan, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023. A press
HAE vs. SYK: Which Stock Is the Better Value Option?
12:46pm, Monday, 25'th Sep 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Stryker's (SYK) New Camera Platform to Improve Surgery Outcomes
01:32pm, Friday, 15'th Sep 2023
Stryker's (SYK) latest camera platform is likely to enhance the surgical experience across specialties.
Stryker (SYK) Gets FDA 501k Clearance for Pangea Trauma Systems
09:46am, Wednesday, 13'th Sep 2023
Stryker's (SYK) Pangea systems will boost the company's Trauma business unit following a complete launch. SYK plans to present the new system at the Annual Orthopaedic Trauma Association meeting.
Stryker Corporation (SYK) Wells Fargo Securities Healthcare Conference (Transcript)
09:37pm, Thursday, 07'th Sep 2023
Stryker Corporation (NYSE:SYK ) Wells Fargo Securities Healthcare Conference Call September 7, 2023 3:00 PM ET Company Participants Glenn Boehnlein - CFO Jason Beach - VP, IR Conference Call Participa
Stryker upgraded to ‘Buy' on 2024 upside potential
12:08pm, Tuesday, 05'th Sep 2023
Analysts at Bank of America have upgraded their rating on medical technologies company Stryker Corporation (NYSE:SYK) to ‘Buy' on their belief it is likely to be a top-tier performer in 2024. They
Here are 19 stocks Jim Cramer is watching, including Chipotle, LULU and Airbnb
09:32am, Tuesday, 05'th Sep 2023
Here are some of the tickers on my radar for Tuesday, Sept. 5, taken directly from my reporter's notebook.
Reasons to Add Stryker (SYK) Stock to Your Portfolio Now
09:01am, Monday, 04'th Sep 2023
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
A Significant Reversal is in Sight for These 5 Med Tech Companies
09:32am, Wednesday, 30'th Aug 2023
Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normaliz
HAE vs. SYK: Which Stock Is the Better Value Option?
06:48pm, Tuesday, 22'nd Aug 2023
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Stryker (SYK). But which of these two stocks presents investors with the better value o
Final Trades: NextEra Energy, Stryker & Zimmer Holdings
02:10pm, Tuesday, 22'nd Aug 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
07:08am, Tuesday, 22'nd Aug 2023
Stryker's robotic arm technology for knee replacement surgeries positions them as a leader in orthopedic surgeries. The recovery of procedure volumes post-Covid has already contributed to Stryker's or
Is This MedTech Giant a Buy for Dividend Investors?
05:30am, Wednesday, 09'th Aug 2023
Stryker's net sales and earnings climbed in the second quarter. The company's seemingly modest payout could have many more years of growth ahead.
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say
05:18pm, Friday, 04'th Aug 2023
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street es
Is Stryker Corp (SYK) Fairly Valued? An In-depth Analysis
02:33pm, Friday, 04'th Aug 2023
Today, Stryker Corp ( SYK , Financial) experienced a daily change of 3.27%, with an Earnings Per Share (EPS) of 6.87. The question on the minds of many investors is whether the stock is fairly valued.
